Royal London Asset Management LTD Abbott Laboratories Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Royal London Asset Management LTD holds 744,898 shares of ABT stock, worth $85.1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

744,898

Previous 725,135 2.73%

Holding current value

$85.1 Million

Previous $75.3 Million 12.71%

% of portfolio

0.22%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.98 Million - $2.33 Million	19,763 Added 2.73%	744,898 $84.9 Million
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $3.79 Million - $4.23 Million	-37,601 Reduced 4.93%	725,135 $75.3 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $75,459 - $83,341	-689 Reduced 0.09%	762,736 $86.7 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $1.62 Million - $1.98 Million	17,950 Added 2.41%	763,425 $84 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $3.27 Million - $3.92 Million	34,214 Added 4.81%	745,475 $72.2 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $10.2 Million - $11.3 Million	100,857 Added 16.52%	711,261 $77.5 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $1.11 Million - $1.31 Million	11,480 Added 1.92%	610,404 $61.8 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $2.31 Million - $2.71 Million	24,270 Added 4.22%	598,924 $65.8 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $3.18 Million - $3.68 Million	-32,886 Reduced 5.41%	574,654 $55.6 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $401,849 - $485,707	3,937 Added 0.65%	607,540 $66.1 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.73 Million - $2.11 Million	15,149 Added 2.57%	603,603 $71.5 Million
Q4 2021 Oct 18, 2022	SELL	$115.53 - $141.46 $2.29 Million - $2.8 Million	-19,782 Reduced 3.25%	588,454 $82.8 Million
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $2.29 Million - $2.8 Million	-19,782 Reduced 3.25%	588,454 $82.8 Million
Q3 2021 Oct 18, 2022	SELL	$116.66 - $129.06 $2.65 Million - $2.93 Million	-22,734 Reduced 3.6%	608,236 $71.8 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $2.65 Million - $2.93 Million	-22,734 Reduced 3.6%	608,236 $71.8 Million
Q2 2021 Oct 18, 2022	BUY	$105.79 - $124.53 $2.48 Million - $2.92 Million	23,430 Added 3.86%	630,970 $73.1 Million
Q1 2021 Oct 17, 2022	BUY	$108.84 - $128.23 $2.55 Million - $3 Million	23,430 Added 3.86%	630,970 $75.6 Million
Q1 2021 Apr 13, 2021	SELL	$108.84 - $128.23 $134,852 - $158,876	-1,239 Reduced 0.2%	630,970 $75.6 Million
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $2.93 Million - $3.2 Million	-27,926 Reduced 4.23%	632,209 $69.2 Million
Q3 2020 Nov 04, 2020	SELL	$91.64 - $111.29 $138,009 - $167,602	-1,506 Reduced 0.23%	660,135 $69.4 Million
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $1.8 Million - $2.3 Million	-23,505 Reduced 3.43%	661,641 $58.9 Million
Q1 2020 May 01, 2020	SELL	$62.82 - $91.86 $38,068 - $55,667	-606 Reduced 0.09%	685,146 $54.4 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $1.19 Million - $1.33 Million	15,190 Added 2.27%	685,752 $59.5 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $54.9 Million - $59.5 Million	670,562 New	670,562 $56.1 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $49.1 Million - $57.3 Million	-673,788 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $4.38 Million - $5.29 Million	-66,123 Reduced 8.94%	673,788 $0
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $19.7 Million - $22.4 Million	-301,164 Reduced 28.93%	739,911 $52.6 Million
Q3 2018 Nov 08, 2018	BUY	$60.81 - $73.36 $20.6 Million - $24.8 Million	337,987 Added 48.07%	1,041,075 $0
Q2 2018 Sep 19, 2018	BUY	$57.57 - $63.54 $40.5 Million - $44.7 Million	703,088 New	703,088 $42.9 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Abbott Laboratories Transaction History